Emergent BioSolutions (EBS) Times Interest Earned (2011 - 2026)
Emergent BioSolutions (EBS) posted quarterly Times Interest Earned of $0.8 for Q1 2026, down 73.18% year-over-year from $2.99 in Q1 2025, and up 142.23% quarter-over-quarter from -$1.9 in Q4 2025.
Emergent BioSolutions (EBS) Times Interest Earned (2011 - 2026) Analysis & Trends
Emergent BioSolutions' Times Interest Earned history runs 16 years deep, the most recent figure standing at $0.8 for Q1 2026.
- In Q1 2026, Times Interest Earned fell 73.18% year-over-year to $0.8; the TTM figure through Mar 2026 stood at $1.02 (up 158.16% YoY), while the FY2025 annual figure was $0.3, up 194.71% from the prior year.
- Times Interest Earned for Q1 2026 stood at $0.8, up from -$1.9 in the prior quarter.
- The five-year high for Times Interest Earned was $7.77 in Q3 2024, with the low at -$12.29 in Q3 2023.
- The 5-year median for Times Interest Earned is -$1.9 (2025), against an average of -$2.62.
- The sharpest annual moves came in 2022 and 2024: Times Interest Earned sank 1284.87% in 2022, then surged 163.23% in 2024.
- Emergent BioSolutions' Times Interest Earned stood at -$5.22 in 2022, then surged by 61.31% to -$2.02 in 2023, then jumped by 39.66% to -$1.22 in 2024, then tumbled by 55.83% to -$1.9 in 2025, then jumped by 142.23% to $0.8 in 2026.
- Business Quant data shows EBS's Times Interest Earned at $0.8 in Q1 2026, -$1.9 in Q4 2025, and $5.03 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Emergent BioSolutions | 261.35 Mn | 120.45 Mn | 137.20 Mn | -12.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.51 |
| Mar 31, 2026 | 0.80 |
| Dec 31, 2025 | -1.90 |
| Sep 30, 2025 | 5.03 |
| Jun 30, 2025 | 0.05 |
| Mar 31, 2025 | 2.99 |
| Dec 31, 2024 | -1.22 |
| Sep 30, 2024 | 7.77 |
| Jun 30, 2024 | -8.62 |
| Mar 31, 2024 | 1.64 |
| Dec 31, 2023 | -2.02 |
| Sep 30, 2023 | -12.29 |
| Jun 30, 2023 | -10.24 |
| Mar 31, 2023 | -6.83 |
| Dec 31, 2022 | -5.22 |
| Sep 30, 2022 | -5.33 |
| Jun 30, 2022 | -9.78 |
| Mar 31, 2022 | 0.59 |
| Dec 31, 2021 | 39.83 |
| Sep 30, 2021 | -5.32 |